Microarray and next-generation sequencing to analyse gastric cancer

Yuan Dang1, Ying-Chao Wang, Qiao-Jia Huang

  • 1Department of Experimental Medicine, Fuzhou General Hospital (Dongfang Hospital), Fuzhou, China

Summary

Gastric cancer research uses microarray and next-generation sequencing (NGS) to find new treatments. These technologies help identify molecular targets for personalized gastric cancer therapies, though challenges remain in clinical application.